Cina Produttore di polvere di steroidi anabolizzanti
EnglishAfrikaansБългарскиNederlandsFrançaisDeutschItaliano日本語LatīnaNorskپارسیPolskiPortuguêsRomânăРусскийSlovenčinaSlovenščinaEspañolSvenskaTürkçeУкраїнськаудмурт кыл

Peptidi farmaceutici

» peptidi » Peptidi farmaceutici

  • specificazioni
  • Descrizione del prodotto
  • Utilizzo del prodotto
  • COA
nome del prodotto Triptorelin Acetate
N. CAS. 140194-24-7
MF C64H82N18O13
MW 1311.45
EINECS n. N / A
Purezza 99%
Aspetto esteriore White freeze dried powder
Magazzinaggio Store at -20°C

Triptorelin is a gonadotropin-releasing hormone agonist used as the acetate or pamoate salts. By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone and follicle stimulating hormone. Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions, and in assisted reproduction. Triptorelin is marketed under the brand names Decapeptyl and Diphereline and Gonapeptyl.

Triptorelin,a decapeptide (pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2), is a gonadotropin-releasing hormone agonist (GnRH agonist) used as the acetate or pamoate salts. By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction. It is also used as therapy in cases of gender dysphoria.

Triptorelin is a GNRH agaonist shown to inhibit estradiol-induced cancer cell proliferationIn vivo.

1. Triptorelin can improve the pregnancy rate by 12% a 15% in ewes6 and downregulate ovarian GNRHR-I expression of female rats, especially in late-growing follicles.

2. Triptorelin immunity blocked EET and UWT, inhibited uterine growth and development and enhance the expression levels s of ESR1, LHR, and FSHR proteins.

3. Triptorelin may be used in the treatment of hormone-responsive cancers such as breast cancer or prostate cancer, precocious puberty, estrogen-dependent conditions, and assisted reproduction.

Singola impurità (HPLC): 1.0%max
Composizione di amminoacidi: ±10% del teorico
Contenuto peptidico (N%): ≥80,0%
Contenuto di acqua(Karl Fischer): ≤6,0%
Triptorelin Acetate Acetate Content (HPC): ≤15,0%
Triptorelin Acetate MS(ESI): Coerente
Triptorelin Acetate Mass Balance: 95.0~105,0%
Triptorelin Acetate Specific Rotation (20/D): -65.0~-75.0°(c=0.5 1%HAc)

Modulo di richiesta ( vi risponderemo nel più breve tempo possibile )

Nome:
*
E-mail:
*
Messaggio:

Verifica:
3 + 7 = ?

Forse ti piace anche

  • Il nostro vantaggio

    Buon prezzo

    Alta qualità

    Consegna veloce

    Spedizione sicura

    Ottimo servizio post vendita

  • Magazzino Locale

    Magazzino UE

    Magazzino nel Regno Unito

    Magazzino USA

    Magazzino canadese

    Magazzino Australiano

  • Metodo di pagamento

    Paypal

    Bitcoin

    Bonifico bancario

    Soldi Gram

    Western Union

  • Contattaci

    E-mail: jacob@steroid-peptide.com

    WhatsApp: +8615636286252

    Telefono: 0086-15636286252

    Sito web: www.steroid-peptide.com

    Benvenuto la tua richiesta